Start a conversation
Home/Communities/Metavex
Me

Prescription products · Product label record

Metavex drug information

METAVEX
Oncora Pharma, LLC · ORAL

Product NDC: 85477-503

Join the community
CommunityExperiencesReviewsDrug database
Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameMETAVEX
Labeler / manufacturerOncora Pharma, LLC
RouteORAL
Drug classVitamin D
Product NDC85477-503
Label effective date2026-01-06

Official product label reference

Metavex — Oncora Pharma, LLC

This page contains 7 source sections for METAVEX, oral route. Label set 1ec54297-9b2d-427f-afc9-b18f4f8ffd93, version 2.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Uses described in the label

INDICATIONS AND USAGE Metavex™ is indicated as a prescription dietary supplement for the dietary management of individuals with metabolic health needs where folic acid supplementation is appropriate. Administration: Take two (2) tablets daily with a 12-ounce glass of water, or as directed by a licensed healthcare practitioner.
Dosage and administration — label text
DOSAGE AND ADMINISTRATION Take two (2) tablets daily with a 12-ounce glass of water, or as directed by a licensed healthcare practitioner.
Contraindications
CONTRAINDICATIONS Metavex™ is contraindicated in patients with known hypersensitivity to any of its components.
Warnings
WARNINGS Metavex™ should be administered under the supervision of a licensed medical practitioner. Patients should not exceed the recommended dosage. If adverse reactions occur, discontinue use and consult a healthcare professional.
Product description
DESCRIPTION Metavex™ is a prescription folic acid–containing dietary supplement intended to support metabolic health. Each tablet contains a combination of vitamins, minerals, and botanical ingredients formulated to provide nutritional support.
Precautions
Precautions Folic Acid and Vitamin B12 Deficiency: Folic acid administered alone may be inappropriate for the treatment of pernicious anemia or other megaloblastic anemias where vitamin B12 deficiency is present. Doses of folic acid greater than 0.1 mg daily may mask hematologic signs of pernicious anemia while neurological manifestations continue to progress. Patients with underlying medical conditions or those taking other medications should consult their healthcare provider prior to use.
Supply and packaging
HOW SUPPLIED Metavex™ is supplied as tan, oval tablets in bottles of 30 tablets. NDC 85477-503-30

Official sources and product identifiers

Substances listed: CHOLECALCIFEROL, FOLIC ACID, BLUE AGAVE INULIN (AGAVE TEQUILANA), ELM, ALOE FEROX LEAF, RHAMNUS CATHARTICA BARK

Package NDC codes

85477-503-30

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.